1
EXHIBIT 11.1
PARACELSUS HEALTHCARE CORPORATION
COMPUTATION OF EARNINGS (LOSS) PER SHARE
(In thousands, except per share data)
Years Ended December 31
-------------------------------
1996 1995 1994
----------- -------- -------
Primary:
(1) Net income (loss) $ (233,216) $ 3,437 $ 7,823
=========== ======== =======
Shares used in this computation:
Weighted average common shares
outstanding 39,213 29,772 29,772
Shares applicable to stock options
and warrants, net of shares
assumed to be purchased from
proceeds at average market price (a) -- --
----------- -------- -------
(2) Total shares for net income
per share computation 39,213 29,772 29,772
=========== ======== =======
Income (loss) per share:
Continuing operations $ (3.94) $ 0.21 $ 0.26
Discontinued operations (1.81) (0.09) --
Extraordinary loss (0.20) -- --
----------- -------- -------
Net income (loss) per share
(1 divided by 2) $ (5.95) $ 0.12 $ 0.26
=========== ======== =======
Fully Diluted:
(3) Net income (loss) (1) $ (233,216) $ 3,437 $ 7,823
=========== ======== =======
Shares used in this computation:
Total primary shares (2) 39,213 29,772 29,772
Shares applicable to stock options
and warrants in addition to
those used in primary computation
to to the use of period-end market
price when higher than average (a) -- --
----------- -------- -------
(4) Total fully diluted shares 39,213 29,772 29,772
Income (loss) per share:
Continuing operations $ (3.94) $ 0.21 $ 0.26
Discontinued operations (1.81) (0.09) --
Extraordinary loss (0.20) -- --
----------- -------- -------
Net income (loss) per share
(3 divided by 4) $ (5.95) $ 0.12 $ 0.26
=========== ======== =======
(a) The effect of options and warrants were anti-dilutive for the year ended
December 31, 1996. There were no options and warrants outstanding for the
years ended December 31, 1995 and 1994.